1.
Intraocular Pressure Monitoring Using an Implantable Sensor Detects Structural Glaucoma Progression in the EYEMATE-IO Trial.
Micheletti Eleonora, Rao Harsha, Weinreb Robert N, Mansouri Kaweh
Am J OphthalmolMay 20252 citationsCase Series
An implantable IOP sensor's peak IOP and fluctuations correlated with glaucoma progression (RNFL thinning), unlike single office measurements. This suggests continuous monitoring can better predict disease worsening.